Advertisement

Abstract

Nanomaterials are engineered structures with at least one dimension of 100 nanometers or less. These materials are increasingly being used for commercial purposes such as fillers, opacifiers, catalysts, semiconductors, cosmetics, microelectronics, and drug carriers. Materials in this size range may approach the length scale at which some specific physical or chemical interactions with their environment can occur. As a result, their properties differ substantially from those bulk materials of the same composition, allowing them to perform exceptional feats of conductivity, reactivity, and optical sensitivity. Possible undesirable results of these capabilities are harmful interactions with biological systems and the environment, with the potential to generate toxicity. The establishment of principles and test procedures to ensure safe manufacture and use of nanomaterials in the marketplace is urgently required and achievable.

Get full access to this article

View all available purchase options and get full access to this article.

References and Notes

1
R. F. Service, Science304, 1732 (2004).
2
V. L. Colvin, Nat. Biotechnol.21, 1166 (2003).
3
K. Donaldson et al., Occup. Environ. Med.58, 211 (2001).
4
G. Oberdörster et al., Environ. Health Perspect.113, 823 (2005).
5
Royal Society, “Nanoscience and nanotechnologies: Opportunities and uncertainties” (Royal Society, London, 2004); available online at www.nanotec.org.uk/finalReport.htm.
6
K. Donaldson et al., Occup. Environ. Med.61, 727 (2004).
7
K. Donaldson, C. L. Tran, Inhal. Toxicol.14, 5 (2002).
8
A. Nel, Science308, 804 (2005).
9
A. A. Shvedova et al., Am. J. Physiol.289, L698 (2005).
10
A. T. Bell, Science299, 1688 (2003).
11
B. Halliwell, J. M. C. Gutteridge, Free Radicals in Biology and Medicine (Oxford Univ. Press, Oxford, 1999).
12
G. G. Xiao et al., J. Biol. Chem.278, 50781 (2003).
13
F. Gilliland et al., Lancet363, 119 (2004).
14
W. S. Beckett et al., Am. J. Respir. Crit. Care Med.171, 1129 (2005).
15
N. Li et al., Environ. Health Perspect.111, 455 (2003).
16
L. L. Dugan et al., Proc. Natl. Acad. Sci. U.S.A.94, 9434 (1997).
17
H. H. C. Chen et al., Toxicol. Path.26, 143 (1998).
18
E. Oberdörster, Environ. Health Perspect.112, 1058 (2004).
19
A. A. Shvedova et al., J. Toxicol. Environ. Health Part A66, 1909 (2003).
20
N. A. Monteiro-Riviere et al., Toxicol. Lett.155, 377 (2005).
21
D. B. Warheit et al., Toxicol. Sci.77, 117 (2004).
22
C. W. Lam et al., Toxicol. Sci.77, 126 (2004).
23
M. D. Geller et al., Aerosol Sci. Technol.36, 748 (2002).
24
A. A. Vertegel et al., Langmuir20, 6800 (2004).
25
A. Nemmar et al., Circulation105, 411 (2002).
26
J. S. Brown et al., Am. J. Respir. Crit. Care Med.166, 1240 (2002).
27
J. Rejman et al., Biochem. J.377, 159 (2004).
28
I. Raynal et al., Investig. Radiol.39, 56 (2004).
29
J. S. Patton, Adv. Drug Deliv. Rev.19, 3 (1996).
30
P. Somasundaran et al., J. Cosmet. Sci.55, S1 (2004).
31
R. D. Brook et al., Circulation109, 2655 (2004).
32
S. S. Tinkle et al., Environ. Health Perspect.111, 1202 (2003).
33
S. Kim et al., Nat. Biotechnol.22, 93 (2004).
34
A. Nel et al., J. Allergy Clin. Immunol.102, 539 (1998).
35
B. Chen et al., Proc. Natl. Acad. Sci. U.S.A.95, 10809 (1998).
36
W. Kreyling et al., J. Toxicol. Environ. Health Part A65, 1513 (2002).
37
S. Yamago et al., Chem. Biol.2, 385 (1995).
38
G. Oberdörster et al., Inhal. Toxicol.16, 437 (2004).
39
More information is available online at http://ntp-server.niehs.nih.gov.
40
G. Oberdörster et al., Part. Fibre Toxicol.2, 8 (2005).
41
We apologize for the many seminal contributions that have not been cited for lack of space. This work was supported by U.S. Public Health Service grants RO-1 ES10553, RO1 ES12053, RO1 ES013432, and PO1 AI50495 (UCLA Asthma and Immunology Disease Center), and by the U.S. EPA (STAR grant to the Southern California Particle Center and Supersite). This manuscript has not been subjected to the EPA's peer and policy review. L.M. was supported by the Parson's chair at UCLA.

(0)eLetters

eLetters is a forum for ongoing peer review. eLetters are not edited, proofread, or indexed, but they are screened. eLetters should provide substantive and scholarly commentary on the article. Embedded figures cannot be submitted, and we discourage the use of figures within eLetters in general. If a figure is essential, please include a link to the figure within the text of the eLetter. Please read our Terms of Service before submitting an eLetter.

Log In to Submit a Response

No eLetters have been published for this article yet.

Information & Authors

Information

Published In

Science
Volume 311 | Issue 5761
3 February 2006

Submission history

Published in print: 3 February 2006

Permissions

Request permissions for this article.

Authors

Affiliations

Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
California NANOSystems Institute, University of California, Los Angeles, CA 90095, USA.
Tian Xia
Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Lutz Mädler
Department of Chemical and Biomolecular Engineering, University of California, Los Angeles, CA 90095, USA.
Ning Li
Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.

Notes

*
To whom correspondence should be addressed. E-mail: [email protected]

Metrics & Citations

Metrics

Article Usage

Altmetrics

Citations

Cite as

Export citation

Select the format you want to export the citation of this publication.

Cited by

  1. Inhalation delivery of dexamethasone with iSEND nanoparticles attenuates the COVID-19 cytokine storm in mice and nonhuman primates, Science Advances, 9, 24, (2023)./doi/10.1126/sciadv.adg3277
    Abstract
  2. Policy reforms to update chemical safety testing, Science, 355, 6329, (1016-1018), (2021)./doi/10.1126/science.aak9919
    Abstract
  3. Reconstituting Organ-Level Lung Functions on a Chip, Science, 328, 5986, (1662-1668), (2021)./doi/10.1126/science.1188302
    Abstract
  4. Nanoparticle technology and its implications in endodontics: a review, Biomaterials Research, 24, 1, (2020)./doi/10.1186/s40824-020-00198-z
    Abstract
  5. How safe are nanomaterials?, Science, 350, 6259, (388-389), (2015)./doi/10.1126/science.aad0768
    Abstract
  6. Geoengineering: Perilous Particles, Science, 340, 6132, (548-549), (2013)./doi/10.1126/science.340.6132.548-b
    Abstract
Loading...

View Options

Check Access

Log in to view the full text

AAAS ID LOGIN

AAAS login provides access to Science for AAAS Members, and access to other journals in the Science family to users who have purchased individual subscriptions.

Log in via OpenAthens.
Log in via Shibboleth.

More options

Purchase digital access to this article

Download and print this article for your personal scholarly, research, and educational use.

Purchase this issue in print

Buy a single issue of Science for just $15 USD.

View options

PDF format

Download this article as a PDF file

Download PDF

Full Text

FULL TEXT

Media

Figures

Multimedia

Tables

Share

Share

Share article link

Share on social media